Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits

1. The anti-diabetic drug miglitol, an α-glucosidase inhibitor, which is currently used clinically, reduces myocardial infarct size by reducing the glycogenolytic rate through inhibition of the α-1,6-glucosidase of glycogen-debranching enzyme in the heart. Nicorandil, a K(ATP) channel opener with a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Minatoguchi, Shinya, Wang, Ningyuan, Uno, Yoshihiro, Arai, Masazumi, Hashimoto, Kazuaki, Hashimoto, Yasuko, Chen, Xue-Hai, Takemura, Genzou, Fujiwara, Hisayoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: 2001
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1572872/
https://ncbi.nlm.nih.gov/pubmed/11487514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0704166
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky